Tag Archives: Novartis
-
-
Data Used To Approve Zolgensma Gene Therapy Treatment May Have Been Manipulated: FDA
-
J&J Ads Contain Misleading Safety Stats On Tremfya, Novartis Lawsuit Claims
-
Generic Drug Safety Concerns Refuted By FDA Amid Continuing Valsartan Recall Problems
-
Valsartan Impurity Problems May Have Resulted From Attempts to Increase Yield: Report
-
JAMA Researcher Failed to Disclose Millions In Industry Payments, Sparking Conflict Of Interest Debate
-
Tasigna Stroke Lawsuit Not Preempted By Federal Law, Judge Rules
-
Valsartan Recalls Announced By FDA Over Impurities, Cancer Risks
-
Zofran, Entresto Recall Issued Over Risk of Child Poisoning Due to Unsafe Packaging
-
Generic Diovan Recall Issued Over Cancer Risks Worldwide, But Not In U.S.